Medicinova Stock Price on August 29, 2024
| MNOV Stock | USD 2.17 0.01 0.46% |
Below is the normalized historical share price chart for MediciNova extending back to December 07, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of MediciNova stands at 2.17, as last reported on the 21st of December, with the highest price reaching 2.22 and the lowest price hitting 2.15 during the day.
If you're considering investing in MediciNova Stock, it is important to understand the factors that can impact its price. MediciNova appears to be risky, given 3 months investment horizon. MediciNova has Sharpe Ratio of 0.0608, which conveys that the firm had a 0.0608% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MediciNova, which you can use to evaluate the volatility of the firm. Please exercise MediciNova's Downside Deviation of 4.28, risk adjusted performance of 0.0736, and Mean Deviation of 3.85 to check out if our risk estimates are consistent with your expectations.
Total Stockholder Equity is likely to drop to about 50.9 M in 2024. Common Stock Shares Outstanding is likely to drop to about 24.6 M in 2024. At this time, MediciNova's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 1.63 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (10.40) in 2024. MediciNova Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of February 2005 | 200 Day MA 1.5807 | 50 Day MA 1.933 | Beta 0.769 |
MediciNova |
Sharpe Ratio = 0.0608
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MNOV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.49 actual daily | 66 66% of assets are less volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average MediciNova is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MediciNova by adding it to a well-diversified portfolio.
Price Book 1.915 | Enterprise Value Ebitda (2.65) | Price Sales 106.4303 | Shares Float 42.1 M | Wall Street Target Price 8.3333 |
MediciNova Main Headline on 29th of August 2024
MediciNova Receives Notice of Allowance from United States P... by finance.yahoo.com
LA JOLLA, Calif., Aug. 29, 2024 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange , announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers MN-166 for post-COVID conditions. The Method of Use patent covers administering a therapeutically effective doses of ibudilast
MediciNova Valuation on August 29, 2024
It is possible to determine the worth of MediciNova on a given historical date. On August 29, 2024 MediciNova was worth 1.36 at the beginning of the trading date compared to the closed value of 1.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MediciNova stock. Still, in general, we apply an absolute valuation method to find MediciNova's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MediciNova where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MediciNova's related companies.
| Open | High | Low | Close | Volume | |
| 1.47 | 1.47 | 1.33 | 1.37 | 16,529 | |
08/29/2024 | 1.36 | 1.37 | 1.31 | 1.31 | 44,069 |
| 1.42 | 1.50 | 1.40 | 1.50 | 116,058 |
| Backtest MediciNova | | | MediciNova History | | | MediciNova Valuation | Previous | Next |
MediciNova Trading Date Momentum on August 29, 2024
| On August 30 2024 MediciNova was traded for 1.50 at the closing time. The top price for the day was 1.50 and the lowest listed price was 1.40 . The trading volume for the day was 116.1 K. The trading history from August 30, 2024 was a factor to the next trading day price increase. The trading delta at closing time against the next closing price was 14.50% . The trading delta at closing time against the current closing price is 55.73% . |
MediciNova Fundamentals Correlations and Trends
By evaluating MediciNova's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MediciNova's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MediciNova financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MediciNova Stock history
MediciNova investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MediciNova is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MediciNova will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MediciNova stock prices may prove useful in developing a viable investing in MediciNova
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 49 M | 24.6 M | |
| Net Loss | -12.7 M | -13.3 M |
MediciNova Quarterly Net Working Capital |
|
MediciNova Stock Technical Analysis
MediciNova technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MediciNova Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
MediciNova cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MediciNova December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how MediciNova stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MediciNova shares will generate the highest return on investment. By undertsting and applying MediciNova stock market strength indicators, traders can identify MediciNova entry and exit signals to maximize returns
MediciNova Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MediciNova's price direction in advance. Along with the technical and fundamental analysis of MediciNova Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MediciNova to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0736 | |||
| Jensen Alpha | 0.6355 | |||
| Total Risk Alpha | 0.3936 | |||
| Sortino Ratio | 0.136 | |||
| Treynor Ratio | (0.43) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.